Bulimia Nervosa Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Bulimia Nervosa Epidemiology Forecast Report Coverage

Expert Market Research's “Bulimia Nervosa Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of bulimia nervosa. It projects the future incidence and prevalence rates of bulimia nervosa cases across various populations. The study covers age, gender, and type as major determinants of the bulimia nervosa population. The report highlights patterns in the prevalence of Bulimia Nervosa over time and projects future trends based on multiple variables.

Bulimia Nervosa Understanding: Disease Overview

Bulimia nervosa is a serious eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviors such as self-induced vomiting, misuse of laxatives, fasting, or excessive exercise. It typically develops during adolescence or early adulthood and is influenced by psychological distress, body image dissatisfaction, and sociocultural pressures. The disorder involves a cycle of loss of control during binge episodes and guilt-driven purging behaviors. Two clinical types are recognized: the purging type and the non-purging type, differentiated by the methods used to prevent weight gain.

Bulimia Nervosa Epidemiology Perspective

The bulimia nervosa epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for bulimia nervosa epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for bulimia nervosa and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to the National Eating Disorders Association, global eating disorder prevalence increased from 3.5% to 7.8% between 2000 and 2018. Bulimia nervosa constitutes a significant proportion, with lifetime prevalence estimated at 0.5% in women and 0.1% in men, as per Evelyn Attia et al., 2026.
• As per Elena Ilaria Capuano et al., 2025, the lifetime prevalence of bulimia nervosa ranges from 0.8% to 2.6% among women and 0.1% to 0.2% among men. Among adolescents aged 11–19 years, eating disorders affect 1.2% of boys and 5.7% of girls.
• According to Elena Ilaria Capuano et al., 2025, bulimia nervosa commonly affects adolescents (10–19 years) and young adults (20–40 years), particularly in Western countries, where eating disorders are among the most prevalent psychiatric conditions and show markedly high mortality rates.
• As per the National Eating Disorders Association, approximately 8.60% of females and 4.07% of males experience an eating disorder during their lifetime. Furthermore, one person dies every 52 minutes due to an eating disorder, highlighting the substantial mortality burden associated with bulimia nervosa.
• According to Yihao Ge et al., 2025, nearly 80–90% of individuals with bulimia nervosa experience at least one mood disorder episode during their lifetime, with depressive episodes being most common, reflecting the high psychiatric comorbidity and increased clinical complexity of the disorder.

Read more about this report - Request a Free Sample

Country-wise Bulimia Nervosa Epidemiology

The bulimia nervosa epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Overall, the epidemiological burden of bulimia nervosa and related eating disorders remains substantial across the covered regions. According to the National Eating Disorders Association, approximately 9% of the United States population, or nearly 30 million Americans, will experience an eating disorder during their lifetime. As per the National Health Service, around 700,000 individuals in the United Kingdom are affected by eating disorders. In Japan, according to the Department of Behavioral Medicine, eating disorders including bulimia nervosa account for more than 200,000 patients, reflecting a considerable regional disease burden.

Bulimia Nervosa: Treatment Overview

Treatment of bulimia nervosa involves a multidisciplinary approach combining psychotherapy, pharmacotherapy, and nutritional rehabilitation. Cognitive Behavioral Therapy is considered the first-line psychological intervention, focusing on modifying distorted thoughts and eating behaviors. Interpersonal Therapy may also be effective in addressing underlying emotional triggers. Pharmacological treatment commonly includes selective serotonin reuptake inhibitors, particularly fluoxetine, to reduce binge-purge cycles and depressive symptoms. Nutritional counseling supports the establishment of regular eating patterns. In severe cases with medical complications, short-term hospitalization may be required to stabilize electrolyte imbalances and ensure patient safety.

Key Questions Answered

• What are the key findings of bulimia nervosa epidemiology in the 8 major markets?
• What will be the total number of patients with bulimia nervosa across the 8 major markets during the forecast period?
• What was the country-wise bulimia nervosa epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of bulimia nervosa patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of bulimia nervosa the forecast period of 2026-2035?
• What are the currently available treatments for bulimia nervosa?
• What are the risks, signs, symptoms, and unmet needs of bulimia nervosa?

Scope of the Bulimia Nervosa Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of bulimia nervosa based on several factors.
• Bulimia Nervosa Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The bulimia nervosa report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Binge Eating Disorder Market

Binge-Eating Disorder Pipeline Analysis Report